Brief: Impel Pharmaceuticals Inc - QTRLY Net Losses Were $31.1 Mln Or $1.31 Per Common Share
14/11/2022 13:03
Nov 14 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS INC - QTRLY NET LOSSES WERE $31.1
MILLION
OR $1.31 PER COMMON SHARE
* IMPEL PHARMACEUTICALS INC - NON-GAAP NET LOSS PER SHARE
FOR THE
THIRD QUARTER 2022 WERE $1.31
Further company coverage: IMPL.O
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq